دورية أكاديمية

PB0924 Venous Thromboembolism Risk in Lung Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Versus Chemotherapy

التفاصيل البيبلوغرافية
العنوان: PB0924 Venous Thromboembolism Risk in Lung Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Versus Chemotherapy
المؤلفون: Li, A., May, S., La, J., Martens, K., Amos, C., Flowers, C., Do, N., Brophy, M., Chitalia, V., Ravid, K., Gaziano, J., Fillmore, N.
المصدر: In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2
قاعدة البيانات: ScienceDirect
الوصف
تدمد:24750379
DOI:10.1016/j.rpth.2023.101772